Podcasts about Pharmacy

Specialty pharmacy is becoming one of the most important access points in modern healthcare, particularly for patients managing complex, chronic, rare, and high-cost conditions. As therapies advance and patient needs become more sophisticated, health systems are rethinking how specialty pharmacy can improve medication access, continuity of care, clinical outcomes, affordability, and the overall patient experience.   In this special episode of This Week in Pharmacy, the Pharmacy Podcast Network introduces Specialty Care Close to Home, a new series examining how hospitals and health systems are designing, building, supporting, and scaling specialty pharmacy services across health-system and community-based care models.   Featured Guests   Dr. Laura Mark, PharmD Vice President of Pharmacy, Allegheny Health Network   Allison Arant Senior Vice President, Clearway Health   Chris Corsi Chief Executive Officer, CassianRx   Together, the guests discuss why health-system specialty pharmacy expansion matters, what successful programs require, and where the greatest strategic and operational challenges exist. The conversation explores how strong partnerships, integrated clinical workflows, patient-centered technology, and coordinated care teams can reduce fragmentation and improve specialty medication access.   Discussion Highlights The growing strategic role of health-system specialty pharmacy Keeping patients connected to trusted local care teams Improving access, adherence, affordability, and therapy management Building scalable specialty pharmacy infrastructure Integrating clinical, operational, and technology capabilities Overcoming payer, workflow, workforce, and reimbursement challenges Creating collaborative models that support long-term sustainability   Future episodes of Specialty Care Close to Home will explore accreditation, payer access, manufacturer relationships, clinical workflow, patient engagement, technology infrastructure, data reporting, community access, workforce development, and financial sustainability.   The series will also feature pharmacy directors, vice presidents, executives, operators, and innovators from health systems across the country who are leading the next generation of specialty care delivery.   Host: Todd Eury, Founder of the Pharmacy Podcast Network   Coming Soon: Specialty Care Close to Home—a national conversation about bringing advanced specialty pharmacy services closer to where patients live, work, and receive care.

Primary open-angle glaucoma is a progressive eye disease that can lead to irreversible vision loss without timely treatment and ongoing monitoring. This course reviews practical approaches to glaucoma management, including treatment goals, common medication options, and factors that influence adherence and long-term disease control. You will be better prepared to support patients receiving glaucoma therapy through medication counseling, adherence support, and reinforcement of appropriate follow-up care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTStephanie Conway-Allen, PharmDAssociate Professor of Pharmacy Practice,Massachusetts College of Pharmacy and Health Sciences Worcester/ManchesterPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe treatment goals and common management strategies for primary open-angle glaucoma.2. Explain pharmacist-relevant considerations for counseling and supporting patients receiving glaucoma therapy.Rachel Maynard and Stephanie Conway-Allen have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-252-H01-P Initial release date: 7/20/2026Expiration date: 7/20/2029Additional CPE details can be found here.

Welcome to Omni Talk's Retail Daily Minute, sponsored by R&S Logistics, Duvo and Mirakl.In today's Retail Daily Minute, Omni Talk's Chris Walton discusses:Wonder closes a $650 million Series D at a $9 billion valuation, with reports the food-platform company is gearing up for an IPO as early as next year.Instacart acquires Arpalus, an AI-powered shelf-scanning startup, to give its in-store shoppers real-time inventory data via smartphone and Caper Cart cameras.CVS Health opens its first pharmacy-focused store in Houston as it accelerates a scaled-down, pharmacist-centered format nationwide.The Retail Daily Minute has been rocketing up the Feedspot charts, so stay informed with Omni Talk's Retail Daily Minute, your source for the latest and most important retail insights.

Primary open-angle glaucoma is a progressive eye disease that can lead to irreversible vision loss without timely treatment and ongoing monitoring. This course reviews practical approaches to glaucoma management, including treatment goals, common medication options, and factors that influence adherence and long-term disease control. You will be better prepared to support patients receiving glaucoma therapy through medication counseling, adherence support, and reinforcement of appropriate follow-up care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTStephanie Conway-Allen, PharmDAssociate Professor of Pharmacy Practice,Massachusetts College of Pharmacy and Health Sciences -Worcester/Manchester GET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe treatment goals and common management strategies for primary open-angle glaucoma.2. Explain pharmacist-relevant considerations for counseling and supporting patients receiving glaucoma therapy. Rachel Maynard and Stephanie Conway-Allen have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-252-H01-P Initial release date: 7/20/2026Expiration date: 7/20/2029Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Senate lawmakers are calling for an independent audit of the Defense Department's multibillion-dollar TRICARE pharmacy program amid concerns that its longtime contractor, Express Scripts, may have a financial incentive to steer beneficiaries toward its own pharmacies. Federal News Network's Anastasia Obis has more.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Jan D. Hirsch, Founding Dean of the University of California, Irvine School of Pharmacy & Pharmaceutical Sciences & Professor of Clinical Pharmacy, discusses how AI, precision medicine, and interdisciplinary education are shaping the future of pharmacy while preparing the next generation of healthcare leaders to improve patient outcomes.

Switching pharmacy management software is one of the biggest decisions an independent pharmacy can make, and one of the most disruptive if done incorrectly. In this episode of Insights Beyond the Counter, we discuss the real considerations behind changing pharmacy management systems: wh y pharmacies decide to switch, what holds them back, and what makes a transition successful. From workflow challenges and data migration concerns to staff training and long-term scalability, this conversation provides practical insight for pharmacy owners evaluating their current system. If you're frustrated with inefficiencies, limited support, outdated technology, or lack of growth tools, this episode will help you better understand what to evaluate before making a move. In   This Episode: • Signs it may be time to consider a new pharmacy management system • Common fears around switching software • What a smooth implementation process should look like • How to minimize workflow disruption during transition • Why long-term partnership and support matter more than price   This is an audio-only episode. Listen in while you work, drive, or catch up between scripts.   To learn more about our Pharmacy Management Software, check us out at https://www.outcomes.com/. For demo, click here: https://www.outcomes.com/request-a-ph...

Through evidence-based counseling and open dialogue, pharmacists help patients make informed decisions, improve medication safety, and build trust — ultimately reducing the spread and impact of misinformation in healthcare.  By understanding study design, bias, statistical significance, and clinical relevance, pharmacists can distinguish sound science from misleading claims. This episode highlights how to discuss this information in a respectful and patient-centered way, addressing concerns without judgment. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

AI in Pharmacy Standards and Drug Supply Chain Upgrades This Week in Pharmacy — July 17, 2026   Artificial intelligence and supply chain modernization are reshaping pharmacy practice, patient access, and healthcare operations.   In this episode of This Week in Pharmacy, host Todd Eury speaks with leaders from URAC and Cencora about responsible AI adoption and the growing gap between drug availability and real-world access.   Guests   Shawn Griffin, MD President and CEO, URAC   Brent Wilhelm Senior Vice President, Global Supply Chain Center of Excellence, Cencora   Tim Weber Pharmacy Operations and Regulatory Executive   AI is already supporting clinical documentation, patient communication, risk prediction, and workflow automation. URAC President and CEO Shawn Griffin, MD, explains why healthcare organizations need clear governance, defined accountability, human oversight, and continuous monitoring before deploying AI at scale.   The discussion addresses transparency, performance evaluation, bias, data integrity, cybersecurity, and the role accreditation standards may play in promoting safe and responsible AI adoption.   Governance and accountability for AI outputs Human review of AI-supported decisions Monitoring safety, accuracy, and bias The role of accreditation in AI oversight Balancing innovation with patient protection   Drug Availability Versus Patient Access   Brent Wilhelm of Cencora discusses why a medication may exist somewhere in the supply chain but still remain difficult for providers to obtain.   Dosage limitations, delivery timing, ordering complexity, reimbursement barriers, cold-chain requirements, and site-of-care restrictions can all delay patient access.   Wilhelm explains why the industry must look beyond inventory levels and focus on whether providers can obtain the correct therapy, at the right location, when the patient needs it.   Inventory visibility versus actual access Differences across pharmacies and sites of care Specialty and temperature-sensitive therapies Provider demand forecasting Reducing delays, shortages, and waste   Tim Weber adds the pharmacy operations and regulatory viewpoint, discussing inventory planning, compliance, product tracing, reimbursement, and patient fulfillment.   The conversation highlights the need for better coordination among manufacturers, distributors, pharmacies, health systems, payers, and regulators.

In this episode, Jen Arnoldi sits down with the Section of Pharmacy Educators Distinguished Service Awardee, Winter Smith, to discuss what membership within the section and ASHP means to her and how it has helped her develop as a pharmacy practice leader.  The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Do you have trouble sleeping? An occasional late night or early morning is probably not dangerous, but too many people get too little sleep on a regular basis. How does that affect their health? Even more importantly, what can they do to change the situation? You'll want to listen to find out if you need a sleep reset. At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, July 18, 2026, through your computer or smart phone (wunc.org). Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on July 20, 2026. The podcast will be available on Monday (July 20, 2026) Do You Need a Sleep Reset? Why is sleep so important for good health? Our guest is a sleep medicine specialist who uses a metaphor of Disneyland. Crucial maintenance on the theme park happens at night, when there are no visitors. Streets are cleaned, flower beds are weeded, and rides are inspected and, if needed, repaired. None of that can happen while the park is open for business. Our bodies and brains also need time for maintenance and repair, and some of that happens while we are sleeping. When we don't get the rest we need, we may find ourselves at increased risk for diabetes, cardiovascular problems, cancer, cognitive challenges and even premature death. Unfortunately, anxiety about not sleeping can keep people awake all on its own. How can people break that cycle? We'll also discuss ways that people can get help avoiding screens at night. That is an important part of a sleep reset. Blue light from the screen signals the brain to be alert instead of relax. Scrolling social media can often be emotionally upsetting, which also makes it more difficult to fall asleep. Is Your Diet Keeping You Awake? Most of us recognize that a big midnight snack, á la Dagwood Bumstead of the Blondie comic, is probably not conducive to sleeping well. How does nighttime eating affect our circadian rhythm? Are there diets that we should avoid because of their impact on sleep? Dr. Seheult describes a study in which volunteers had their sleep stages monitored closely during the time they were consuming different diets (Obesity, July 2023). When they followed a high-fat, high-sugar diet, it disturbed the pattern of their brain waves during what should have been restorative sleep. How Do Sleep Problems Affect Eating Habits? A lot of us are aware that when we are sleep deprived, we are more inclined to become hangry and we may be less discerning about what we eat. A recent study shows that the sleep deprivation can have an effect even if it is fairly mild and short-term. Scientists recruited people who normally sleep seven to eight hours a night and asked them to stay up an extra hour and a half (Annals of Internal Medicine, July 7, 2026).  During the six weeks of that part of the experiment, people were less active during the day. They also ate more, so they gained about a pound, on average, during those six weeks. Presumably, disrupting sleep for a longer period of time would result in greater weight gain and metabolic disruption. Would a Ketogenic Diet Help with a Sleep Reset? A ketogenic diet, in which the body relies on ketones rather than glucose for energy production, may be helpful. In particular, fasting overnight for at least 14 hours helps the body do what it must during sleep time. To figure out when you should stop eating, identify when you usually start to feel sleepy. That should be your bedtime. Having your last meal of the day about three hours before that will generally offer enough time for digestion so that you don't experience reflux in the middle of the night. Morning Light and Afternoon Naps Your sleep reset may depend on getting your own circadian rhythm to synchronize with the rest of the world. That is where early exposure to morning light comes in. It's beginning to feel a bit like The People's Pharmacy is on repeat: get morning light exposure! It sets your system up for feeling awake and alert during the day and starting to feel sleepy as the light fades in the evening. Obviously, this is most helpful for people who work during daylight hours. Those working overnight shifts would have to organize their days differently. People who have trouble falling asleep may be tempted to take a nap in the afternoon to make up for the lost sleep. That could be a mistake, as it relieves the sleep pressure that helps people fall asleep without trying. Learning to Fall Asleep If you interact with parents of very young children, you may have heard of sleep training. People have strong feelings about this, both pro and con. Adults rarely need sleep training, though. What we are more likely to need is “not-sleeping un-training.” Too many people approach the bedroom as though it were a stage, and sleep is the performance. No wonder they may develop some performance anxiety about sleeping! Other individuals have learned to associate the bedroom with tossing, turning and watching the clock. Consequently, their bodies tense up instead of relaxing when they get between the sheets. There is no easy quick fix for this problem, but cognitive behavior therapy for insomnia has been proven effective for most people. How About PM Pain Relievers? Even though there isn't an easy fix for sleep troubles, many people want one. They reach for the PM pain reliever and hope it will offer them a good night's sleep without a prescription. The “PM” part of that pain reliever is an old-fashioned antihistamine called diphenhydramine. You might be more familiar with its brand name: Benadryl. You'll also find it in Tylenol PM, Advil PM and all the other PM meds because it tends to make people feel drowsy. What's wrong with that? To start with, it isn't clear that it remains effective after a week or two. In addition, people with restless leg syndrome often find that it makes their condition worse. Other folks report that diphenhydramine can result in an unpleasant “hangover” the next day, in which they feel drowsy though not asleep for a good part of their waking hours. What Wakes You Up at Night? If your sleep problem is waking in the wee hours and having trouble getting back to sleep, you should consider the possibility that you have sleep apnea. The REM sleep of those early morning hours is not as deep as some other sleep stages. Consequently, an alarm signal from your brain saying you haven't taken a breath for 20 or 30 seconds may be more likely to wake you. Sleep apnea may be treated by providing air so that the pressure props the collapsing airway open. We discuss this in greater detail along with a new alternative to a CPAP machine in the podcast for this week. This Week’s Guest Dr. Roger Seheult is an Associate Clinical Professor at the University of California, Riverside School of Medicine. He is also an Assistant Clinical Professor at the School of Medicine and Allied Health at Loma Linda University. He is quadruple board-certified in Internal Medicine, Pulmonary Diseases, Critical Care Medicine, and Sleep Medicine through the American Board of Internal Medicine. His current practice is in Beaumont, California. He is a critical care physician, pulmonologist, and sleep physician at Optum California. Dr. Seheult lectures routinely across the country at conferences and for medical, PA, and RT societies. He is the director of a sleep lab and the Medical Director for the Crafton Hills College Respiratory Care Program. He is co-founder and presenter for MedCram.com, a site that offers concise and easy-to-follow medical videos on a range of topics. Roger Seheult, MD, MedCram, Loma Linda, UC-Riverside Listen to the Podcast The podcast of this program will be available Monday, July 20, 2026, after broadcast on July 18. You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

Send us Fan MailSend us Fan MailSchedule an Rx AssessmentWhat if your team held the best ideas for growing your pharmacy and you just needed to get out of the way?On this episode of the Bottom Line Pharmacy Podcast, we sit down with Dr. Jay Phipps, owner of Phipps Pharmacy and founder of the Phipps Tank concept, to break down:What Phipps Tank is and how to run it in your pharmacyWhy culture is a bottom line strategy, not just a feel-good initiativeHow psychological safety drives team performance and real revenue growthWhy your fear of change might be your biggest financial liabilityAnd more!More About Our Guest: Dr. Jay Phipps is a Pharmacy Gladiator, Pharmacy Doctor, Founder, Entrepreneur President, and CEO with over 29 years of experience in pharmacy. At Phipps Pharmacy, Dr. Jay leads a team of dedicated and professional Pharmacy Doctors and technicians who provide personalized and high-quality care for patients. Phipps Pharmacy, Inc. is an independent pharmacy with 5 locations in Tennessee and Mississippi. Dr. Jay is also the President and CEO of PhippsCare that focuses on Pharmacy Doctor provided healthcare and Health Insurance Solutions who specializes in medical and pharmacy plans for seniors. Dr. Jay currently serves on multiple Boards of Directors and committees on the national, state, and local levels. He has served as the American Pharmacist Association-Academy Students of Pharmacy National President, on the APhA Board of Trustees, President of the Tennessee Pharmacists Association (TPA), on the Board of Directors for TPA, Chair, Tennessee Pharmacy Research Education Foundation, Co-Chair, Carroll County Drug Prevention Coalition and a District 8 County Commissioner. Dr. Phipps received a Doctor of Pharmacy degree from The University of Tennessee Health Science Center, where he also completed a residency in Drug Information and Pharmacotherapy and is currently pursuing an MBA with a major in Leadership and Strategy from the #1 ranked online MBA program at Indiana University - Kelley School of Business.  Dr. Phipps plans to graduate in the fall of 2024. Connect with Dr. Jay Phipps, PharmD:Jay Phipps LinkedInPharmacy Gladiator WebsitePharmacy Gladiator InstagramPharmacy Gladiator TikTokPharmacy Gladiator YouTubeStay connected with us:FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA Twitter More resources on this topic: Podcast - Becoming a Pharmacy GladiatorPodcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – 2026 Quarter 2 Pharmacy UpdatePodcast – America 250, The history of Pharmacy, Q&A

Jay Bregman, founder and CEO of Andel, joins Over the Counter to discuss the Medicare GLP-1 Bridge Program and what pharmacists and their patients can expect from the initiative as it rolls out in early July 2026 and beyond.

Is the NHS relying on analogue systems in a digital world?In Episode 106, former Health Minister Steve Brine and guest co-host Charlotte Refsum (Director of Health Policy at the Tony Blair Institute) discuss the massive gap between NHS prevention ambitions and real-world execution.From the shockingly low uptake of bowel cancer screening kits in the youngest eligible groups to the government's brand new £10 billion digital transformation plan, they discuss whether technology can finally solve the NHS productivity crisis. Plus, they break down wearable tech for sepsis monitoring, and the future of community pharmacies.

In this podcast, Christine Tabulov discusses the AJHP Note "Creation and implementation of a transplant medication patient education game for adolescents by a pediatric pharmacist and pharmacy students” with host and AJHP Editor in Chief Daniel Cobaugh. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, Andrew Kantor is joined by federal lobbyist David Pore and PCCA's Amy Shank to examine the proposed SAFE Act and its potential impact on compounding pharmacies. The discussion explores concerns that the bill could restrict patient access to compounded medications during drug shortages, impose new limitations on 503A pharmacies, and disproportionately affect legitimate compounders while failing to address bad actors. The episode also unpacks the legislation's connection to GLP-1 demand, adverse event reporting, and the bipartisan politics surrounding the bill, while encouraging listeners to stay engaged in APC's advocacy efforts.

Botulinum toxin products are used across a wide range of therapeutic indications, yet many health systems have not evaluated whether product selection aligns with both clinical evidence and financial stewardship. Matt Groth, Director of Pharmacy and Pharmaceutical Supply Chain Management at the University of Rochester Medical Center, joins Kerry Schwarz to discuss how his team implemented a botulinum toxin stewardship strategy by evaluating evidence, engaging clinicians, and standardizing product selection.   Guest Speaker: Matthew D. Groth, PharmD, MS Director of Pharmacy Pharmaceutical Supply Chain Management University of Rochester Medical Center   Host: Dr. Kerry Schwarz, Pharm.D., MPH Senior Clinical Manager, Evidence-Based Medicine and Outcomes Vizient Center for Pharmacy Practice Excellence    Show Notes:  00:05 Introduction Learn why botulinum toxin stewardship is an emerging opportunity for health systems. Hear how clinical evidence and financial strategy can work together to optimize product selection. 01:25 Reviewing the evidence Explore the evidence supporting available botulinum toxin products, including indications, safety, and dosing considerations. Understand why limited clinical differences between products create opportunities for formulary evaluation. 02:31 Identifying stewardship opportunities Learn how organizations evaluate acquisition costs, reimbursement, payer policies, and contracting opportunities. Discover how financial analysis helps identify opportunities to reduce costs while maintaining quality patient care. 04:29 Implementing a preferred product strategy Hear how provider engagement, financial transparency, and P&T committee support helped drive adoption. Learn how a phased implementation approach increased market share while improving financial performance. 08:11 Lessons learned from implementation Explore the operational considerations that support successful implementation, from inventory management to prior authorizations. Learning why collaboration with physicians, nurses, office staff, and billing teams is essential to long term success. 10:57 Key takeaways Review the core elements of a successful botulinum toxin stewardship strategy. Learn how multidisciplinary collaboration can improve value while maintaining high quality patient care.   Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed  

Super-Pharm and the local importer described the initiative as an innovative e-commerce sales model for Israeli car buyers. Drivers can choose between a compact SUV and a mid-size coupe.

Australians visit the pharmacy more than any other health service. But what's happening behind the scenes? How does the price you pay at the counter get set? How's the pharmacy sector funded? For years, decisions about pharmacy policy have been made through closed-door negotiations. In this podcast, Grattan Associate Reilly Polaschek talks to Grattan Health Program Director Peter Breadon about our report, Future pharmacy: A better deal for patients and taxpayers which charts a path to a fairer, more efficient pharmacy sector. Read our report: https://grattan.edu.au/report/future-pharmacy-a-better-deal-for-patients-and-taxpayers/ Thanks for listening to the Grattan Podcast. Our research, reports and analysis are freely available thanks to the donations of listeners like you. Please consider making a regular or one-off donation at grattan.edu.au/donate. You can follow us on LinkedIn and Instagram, and sign up to our newsletter on our website to stay up to date with Grattan's news. Thanks again for listening. Instagram: www.instagram.com/grattaninstitute/ LinkedIn: www.linkedin.com/company/grattan-institute/

PXY Mornings w/ Moose and Breezy: Pharmacies used to be on the corner of every block, now it seems they just keep closing. The alternative being mailed prescriptions, troubles with that... Small, mom and pop pharmacies have become virtually extinct.

Drs. Alan Zillich and Khoa Nguyen speak with Drs. Kathryn Lin and Morgan Stewart (University of Texas at Austin) and Dr. Tony Olson (Geisinger) about clinical pharmacists using ambientAI documentation tools in ambulatory care. The guests describe workflows using mobile apps integrated with Epic, consent processes, and pharmacist review/editing before signing notes. They discuss implementation rollouts,benefits such as reduced documentation burden, improved attention during encounters, less after-hours work, and support for bilingual Spanish-English visits, as well as challenges like inaccuracies, paraphrasing, and considerations for training student learners. Listen as they summarize their study findings and read the full manuscript here: ⁠https://accpjournals.onlinelibrary.wiley.com/doi/10.1002/jac5.70242.

After years of lobbying and advocacy work by 340B covered entities, the Illinois state legislature approved major 340B legislation earlier this year that protects 340B contract pharmacy access and prohibits drugmaker claims on data demands. Thomas Yu, system director of ambulatory pharmacy services at Sinai Chicago, discusses the campaign that made this legislative victory possible and what covered entities in other states can learn from this success.Joint Events Showed Unity Among Safety-Net ProvidersYu says two “340B Saves Lives” days of action in Chicago helped drive support for the legislative effort. Under the leadership of an association representing community health centers, the events brought together covered entities, patients, lawmakers, and others to show a united front on the issue of protecting 340B.The Story of 340B Resonated With Lawmakers, Not Numbers AloneYu reiterates that statistics and data can be helpful in making the case for 340B but that the story of 340B is what can swing votes. Focusing on community impact and how covered entities use their savings to benefit patients was much more effective at imparting the importance of legislation to protect access to those savings.Illinois Legislation Was a Compromise The legislation package in Illinois contains 340B reporting requirements for covered entities in the state. Yu argues that this compromise was necessary as the contract pharmacy and claims data provisions would have been a “nonstarter” without that addition. However, because the numbers go to the state for a one-time report and because drugmakers also must report data, he says the overall legislative package still makes for a big win for covered entities and patients in the state.ResourcesIllinois Legislature Delivers Contract Pharmacy Victory for 340B HospitalsProposed Medicare Pay Cut for 340B Drugs Would Be Much Deeper Than 2018-2022 Reductions

PPP 194 – Sport and Exercise Pharmacy with Alison Hooper In this episode, pharmacist and former physiotherapist Alison Hooper joins us to discuss the expanding role of pharmacists in sport, exercise, and active living We cover: How pharmacists can support movement, exercise, and sport Injury management and common sports-related conditions Managing chronic conditions in active people Exercise-induced asthma Therapeutic Use Exemptions (TUEs) WADA and anti-doping regulations Accidental doping risks from supplements RICER vs PEACE & LOVE for injury management The latest evidence on NSAIDs in sport Whether you're working with elite athletes or helping patients stay active, this episode highlights the important role pharmacists play in supporting safe participation in sport and exercise.   Further Reading and Resources Links Understanding pharmacists' engagement in sport and exercise medicine, including pharmacist-physiotherapist collaboration: A qualitative study and COM-B analysis. https://www.sciencedirect.com/science/article/pii/S2667276625000344   WADA website: Raising the game for clean sport | World Anti Doping Agency WADA Prohibited List: 2025list_en_final_clean_12_september_2024.pdf Sport Integrity Australia: Protecting Sport Together | Sport Integrity Australia Sports Integrity Australia Sports Pharmacy eLearning Course: New Sports Pharmacy eLearning Course Launched Global Drug Reference Online: Global DRO - Home Sports Integrity Australia 'Check Your Substances' (links to Global DRO) Check Substances On Global DRO | Sport Integrity Australia Informed Sport (Supplement Batch Testing): Sports Supplements Certification | Informed Sport HASTA (Supplement Certification and Testing): Home - HASTA US Sports Pharmacy Group: U.S. Sports Pharmacy Group Sports Pharmacy Network: Sports Pharmacy Network      

When sunny summer days come around, it makes some dermatologists shudder. They would prefer we behave like bats and hide in caves until nightfall. Failing that, they stress the importance of always applying (and re-applying) high SPF sunscreen, wearing sun-blocking clothing with long sleeves and keeping a big-brimmed hat firmly on the head. A beekeeper's outfit might be perfect. But must you really shun the sun completely to save your skin? Our guest describes how to practice moderation safely. He also explains why some people are addicted to sunshine, while others are allergic to it. At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, July 11, 2026, through your computer or smart phone (wunc.org). Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on July 13, 2026. Can You Really Be Addicted to Sunlight? Dermatologists do their best to discourage people from using tanning beds. They describe the damage that ultraviolet light can cause, ranging from wrinkles to skin cancer. For some people, though, those arguments just don't make a difference. Our guest, Dr. Steve Feldman, conducted a study several years ago. The volunteers were accustomed to using tanning beds. In the study, there were two beds, one with the usual ultraviolet light and the other, identical in appearance and temperature, had its UV blocked. After a session in each bed, volunteers were allowed to choose their bed for the last session. They almost invariably chose the bed with the active UV. To follow up, the researchers administered naltrexone, the opioid-blocking medication. When volunteers had taken it, they were no longer able to distinguish which bed was active. It seems that, for these people, ultraviolet light activates pro-opiomelanocortin, which in turn triggers the production of natural opioids called endorphins. Further research imaging the brain during tanning sessions confirmed that the UV exposure was activating areas of the brain associated with pleasure (Psychiatry Research. Neuroimaging, May 30, 2016).  Dr. Feldman and a colleague found that excessive indoor tanning is similar in pattern to substance use disorders (Journal of Cutaneous Medicine and Surgery, May-June 2025). Can You Save Your Skin and Still Enjoy the Outdoors? Dr. Feldman offers advice on avoiding sunburn that is tempered with this fact from epidemiology: people who go out in the sun live longer (International Journal of Environmental Research and Public Health, July 13, 2020).  The goal here is not to shun the sun completely, but rather to exercise enough caution and good judgment to avoid burning your skin. (Who wants to burn, anyway? It hurts, and it looks bad.) Timing your sun exposure carefully is crucial to save your skin from sunburn. You may also be interested in the new sunscreen ingredient the FDA just approved, bemotrizinol. What Can You Do About Heat Rash? When the weather gets hot and bodies get sweaty, heat rash becomes a common complaint. Sweaty skin may develop bumps that can sometimes be very itchy. What do you do to ease the discomfort? If you can cool the skin off, it might help a lot. Of course, people may also suffer from other types of rash. Babies get diaper rash. Women sometimes experience under-breast rash, just as men may develop jock itch. Zinc oxide ointment can often be helpful for these types of rash. Managing Psoriasis Psoriasis is one of Dr. Feldman's special research interests. The red scaly plaques of this skin condition have raised borders. They look a lot like a fungal infection, but there is no fungus present on the skin to cause them. Something else seems to trigger the skin's immune system to react along the same pathways as if there were a fungus. Most of the time, psoriasis is mild enough to manage without costly medications. It actually responds very well to ultraviolet light exposure. UV downregulates the immune system's over-response. While many dermatologists offer UV exposure within their office walls, in the summertime patients could get exposure to sunlight outdoors. This is practical if they avoid the middle of the day, when they might get burned. Another option? Tanning beds also offer an easy way to calibrate the appropriate amount of UV exposure to save your skin from psoriasis. (Most dermatologists don't approve of this one, so don't tell.) One other practical but unorthodox tip for dealing with mild psoriasis. OTC cortisone may not be strong enough to help heal up a red spot. But you could buy Flonase nasal spray or a generic version, fluticasone, over the counter. Spray it on your skin and appreciate the relief. In fact, this could work for a mild case of poison ivy or other skin irritation as well. Severe cases still need a dermatologist's care. What to Do About Atopic Dermatitis Atopic dermatitis is the medical term for eczema. People with allergies or asthma also appear to be more vulnerable to eczema. Dysregulation of the immune mediators interleukin 4 (IL4) or IL13 may be responsible. This condition may appear in a mild form, which can be readily managed, or a more severe form that might require prescription medication. A topical corticosteroid such as triamcinolone will often clear it up. Or you could try spraying on some Flonase nasal spray for a cost-effective low-key approach. Those will actually help the majority of people with mild eczema. Using mild soap rather than detergent-based body wash, moisturizing well and following an anti-inflammatory diet are the pillars of home management. People with more severe atopic dermatitis covering a large portion of the body may need powerful prescription medication rather than topical steroids. Trying to cover so much skin with steroid would probably result in side effects from the cream. Dupixent (dupilumab) is a relatively new self-injectable medication that blocks IL4 and IL13. It works well for most people with atopic dermatitis and has a good safety profile. Certain other drugs in this category, such as Skyrizi (risankizumab), are also pretty safe but very pricey. Stelara (ustekinumab), has been around longer. Biosimilars for Stelara have been approved and are more affordable. Ustekinumab blocks IL12 and IL23. TV ads tout other medicines for this condition as well. Rinvoq (upadacitinib) is three or four times more effective than Dupixent, but it is also super expensive. It is a Janus-kinase (JAK) inhibitor. Xeljanz (tofacitinib) is another potent prescription JAK inhibitor, but it carries an elevated risk of heart attack. Beware of Bug Bites Another summer skin hazard is bug bites. Here unquestionably the best approach to save your skin is avoidance. Appropriate clothing is key. (That beekeeper's suit will come in handy here again.) Dr. Feldman recommends spraying DEET on your pants legs, socks and sleeves rather than directly on your skin. If there are grasses or brush where you have walked, run or played, a tick check immediately upon coming inside is critical. Can AI Help Patients with Skin Problems? It doesn't make sense to tell people to stay off the internet. Some searches can be quite helpful and guide patients in asking their dermatologist the right questions. Dr. Feldman is enthusiastic about DermNet, a New Zealand dermatology website. https://dermnetnz.org  Joe and Terry recommend SkinSight. This Week’s Guest Steven R. Feldman, MD, PhD, is Professor of Dermatology, Pathology, and Social Sciences & Health Policy, at the Wake Forest University School of Medicine.  His research has been published in over 1,000 peer reviewed, Medline-referenced articles. Expertscape.com ranks Feldman among the top experts in the world on psoriasis, acne, dermatology, and treatment adherence. Steve Feldman, MD, in Dermatology clinic, Country Club Commons Listen to the Podcast The podcast of this program will be available Monday, July 13, 2026, after broadcast on July 11. You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

Integrative Care Impact and the Expanding Role of the Pharmacist | TWIRx Today's episode of This Week in Pharmacy explores two major opportunities shaping the future of the profession: the growth of holistic and integrative pharmacy services inside community pharmacies, and the expanding demand for pharmacists across the business, insurance, and PBM sectors. In our first segment, Todd Eury welcomes special guests Robert Kress, RPh, and Dr. Bianca Bradshaw, PharmD, owner of Elmore Pharmacy in Red Bluff, California. Together, they discuss the tremendous opportunity for independent pharmacies to build holistic and integrative health departments that respond to growing consumer demand for natural products, supplements, wellness solutions, and personalized care. Dr. Bianca Bradshaw, PharmD https://www.linkedin.com/in/bianca-bradshaw-141092205/ Patients are increasingly seeking more natural approaches to health, but they still need trusted clinical guidance. Community pharmacists are uniquely positioned to help patients evaluate products, avoid harmful interactions, understand evidence, and develop safer, more effective wellness plans. This conversation explores how pharmacies can create new service lines, improve patient relationships, and establish sustainable revenue opportunities through integrative care. In our second segment, Dr. Bonnie Hui-Callahan, PharmD, returns to the show to discuss career opportunities for pharmacists within Judi Health and Capital Rx, as well as the broader business and insurance side of pharmacy. Dr. Bonnie Hui-Callahan, PharmD https://www.linkedin.com/in/bonnie-hui-callahan/ As PBMs continue to evolve, new-generation models are creating demand for pharmacists who understand clinical care, benefits, formulary strategy, patient access, data, and healthcare economics. Bonnie shares why pharmacists will remain essential as PBMs transform and why the profession should look beyond traditional dispensing and clinical practice roles when considering future career paths. Today's episode is sponsored by Independent Pharmacy Cooperative and SuiteRx. Listen to This Week in Pharmacy on the Pharmacy Podcast Network.

Pharmacy services can impact various facets of healthcare, including improved patient outcomes, enhanced quality and safety measures, and significant cost avoidance or reduction. Join a panel of key leaders as they share insights on identifying, quantifying, and communicating the value and impact of clinical pharmacy services. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

What actually happens after you hand your insurance card to the front desk at a doctor's office? On the pharmacy side, a claim clears in milliseconds. On the medical side, the same visit can trigger a weeks- or months-long odyssey of coding, clearinghouses, carve-outs, and paper claims before anyone knows what's owed. On this episode of Astonishing Healthcare, host Justin Venneri revisits the "story of a claim," this time following the far more complicated journey of a medical claim.Joining him are two guests who've been working to improve medical claims processing for years: Kevin Sundquist (VP, Product) and Liya Lomsadze (Senior Director, Product). Together, they trace why medical claims lag, why the system got carved into so many disconnected pieces, and how unifying medical and pharmacy benefits on a single platform - Judi® - changes the experience for plan sponsors, members, and providers.HighlightsWhile pharmacy claims are adjudicated in real time, medical claims often can't even be created on the spot. The clinical record and billing system are frequently separate, and each handoff adds lag and introduces new chances for error – a single mislabeled insurance record can delay a simple lab claim by six months.In the medical world, it's common to split a single claim's journey across multiple vendors: in-network pricing to one entity, out-of-network pricing to another, prior authorization to a third, and benefit application to yet another. Plan sponsors, brokers, and consultants need one system and the flexibility to carve out any piece to a preferred partner if they'd like.Rigid legacy systems force unnecessary compromises and workarounds. Manual tracking of visits to a chiropractor or physical therapist and hacking deductibles for plan members are all too common.Judi's capabilities are expanding. Payments, care navigation and management, case management, and much more are brought into a more connected experience for members, sponsors, and providers.Related ContentAH037 - The Story of a Claim: Redefining the Benefit Experience, with Kevin SundquistTop 10 New Judi® Updates Improving Health Benefits AdministrationAH094 - How Unified Claims Processing Evolved from Pharmacy: Improving Member Care & Operating EfficiencyFor more information about this episode and its transcript, please visit Judi Health Insights.

Send us Fan MailHerbs can support us in so many ways. Whether you're looking to make healthier and more flavorful meals, strengthen your immune system, or find natural support for a chronic health condition, my guest Ruth Shelton believes there's an herb that can help. Her motto is "A Better Life Through Herbs" In this conversation Ruth shares how herbs can become part of our everyday life, what people often misunderstand about herbal medicine, and how we can use nature to support our health in safe, effective, and practical ways.Ruth is a clinical herbalist with more than 20 years of experience helping people improve their health through the power of medicinal plants. She isn't afraid to think outside the box to find the best herbal combinations to create personalized formulations for her clients. Ruth, The Empirical Herbalist, also grows about one-third of the organic and biodynamic herbs she uses in her own products, giving her a unique connection to the plants she works with—from seed to remedy.What a pleasure to have another fellow East TN Wellness Directory member in the podcast! CONNECT WITH RUTH: https://www.theempiricalherbalist.com/Instagram: https://www.instagram.com/empiricalherbalist/Download my FREE eBook: A Weekend of Feeling GreatIf you enjoyed this episode, please FOLLOW, RATE, REVIEW & SHARE!! Rates and reviews help the message get to more people! Thanks!Good is What Makes You Feel Well is Mamma Terra's PodcastCONNECT WITH MAMMA TERRA HEALTH COACHING:Instagram: @mammaterrahcSchedule a FREE Discovery call Sign up for my free weekly newsletter: HEREBuy my book Living Your Best Life in CollegeTake the 2-minute Wellness QuizIntro Music "Levitar" credits to Ricardo Ulpiano, Thiago Peixoto, Marcelo Luciano Menino, and Anderson Rodrigo de Oliveira.Podcast art credits to Caroline Kohls Thanks for tuning in!

NO ADS on PATREON: www.patreon.com/dopeypodcast This week on Dopey! Dave opens in a reflective mood before vacation, trying to practice gratitude while also admitting how ridiculous and uncomfortable it feels. He gives thanks to the Dopey team, Dopey Nation, the people who helped with the film festival, and talks about being sober, scrambling to get shows done, House of the Dragon, and crying on the Long Island Railroad while watching the Knicks finals mini movie. Then Dave gets into revenge, resentment, recovery, redemption, and the dangerous romance of “getting back.” He plays a wild voicemail from a Scottish Dopey listener coming off opiates, who tells a story about buying a house, snorting heroin before move-in day, doing coke, champagne, and Ritalin while moving furniture, crashing a van, watching his friend get arrested, and then finishing the move on a days-long stimulant binge. Then it's a classic Dopey replay with Michael Todd, former bassist of Coheed and Cambria. Michael tells the story of going from prescription painkillers on tour to OxyContin, heroin, shooting coke and dope, leaving the band, rejoining clean, relapsing, smuggling heroin across the country in Gobstopper boxes, robbing a pharmacy in Massachusetts, getting arrested, losing the band for good, dealing with cancer, shame, probation, relapse, Suboxone, and surviving a suicide attempt. It's one of the rawest Dopey conversations ever: rock stardom, addiction, shame, survival, recovery, and Dave's newly coined phrase — radical gratitude. PLUS MORE!!!! MORE! MORE!   Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send us Fan MailSchedule an Rx AssessmentAdding telemedicine as a revenue stream...How do you do it? On this episode of the Bottom Line Pharmacy Podcast, we sit down with Mehrdad Hariri, Founder and CEO of RxConnexion, to break down:The real reason most pharmacies struggle to get tractionHow telemedicine actually works inside a pharmacyWhy telemedicine isn't just for compounding And more!Stay connected with Mehrdad Hariri and RxConnexion: Adding telemedicine as a revenue stream...How do you do it? On this episode of the Bottom Line Pharmacy Podcast, we sit down with Mehrdad Hariri, Founder and CEO of RxConnexion, to break down:The real reason most pharmacies struggle to get tractionHow telemedicine actually works inside a pharmacyWhy telemedicine isn't just for compounding And more!Stay connected with Mehrdad Hariri and RxConnexion: RxConnexion Website: https://www.rxconnexion.com/RxConnexion Facebook: https://www.facebook.com/PSGARXRxConnexion Instagram: https://www.instagram.com/rxconnexion/RxConnexion YouTube: https://www.youtube.com/ ⁨@RxConnexion⁩ RxConnexion TikTok: https://www.tiktok.com/@rxconnexionStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA TwitterMore resources on this topic: Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – 2026 Quarter 2 Pharmacy UpdatePodcast – America 250, The history of Pharmacy, Q&A

Esmé Grewal, JD, joins Over the Counter to discuss the often overlooked support LTC pharmacies provide for aging and other vulnerable patient populations.

In this episode, we break down "From Here to the Pharmacy" as a soldier returns from the Persian Gulf and shows up at Blanche's door — he was her lover before he deployed, and now he's back. The episode handles the reunion with more complexity than a simple love story would, asking what we owe someone who held onto us through something we may have moved past. Blanche is not always good at those calculations, and this episode makes her sit with one she can't charm her way out of.  --- If you would like to support this podcast by making a donation, please do so with cashapp to $pasta26mc

This lecture will serve to enlighten/empower non-dentists with some basic diagnostic & treatment skills to manage dental emergencies in a non-dental setting.

GLP-1 therapies are transforming pharmacy benefits, and Express Scripts is leading the way. Harold Carter, PharmD, SVP of Trade Relations, joins host Eric Glazer to discuss how one of the nation's largest PBMs is navigating this disruptive moment in healthcare. Harold shares how Express Scripts is: Capping costs of GLP-1 therapies to expand patient access while keeping plan spending predictable. Redesigning funding models to strike a balance between affordability, predictability, and outcomes. Leveraging digital tools and AI to reduce friction in the member experience and support long-term adherence. Rethinking formularies not just as cost-control tools but as part of a broader population health and behavioral change ecosystem. You'll also hear his forward-looking perspective on how PBMs will evolve over the next three to five years, and the key questions health plans and employers should be asking today to prepare for the future of pharmacy benefits. About Dr. Harold Carter:   Harold Carter, PharmD, is responsible for leading all interactions and contracting with pharmaceutical manufacturers and oversees strategy and management of Express Scripts' drug formularies, data & insights, client underwriting, and product strategy and development. In his nearly 14 years with the organization, Harold has held numerous leadership roles oriented around critical efforts to lower the cost of prescription drugs and ensuring medication access for Express Scripts clients and members. Harold's previous responsibilities include oversight of the organization's medical pharma contracting and drug procurement teams, as well as leading the strategy, development and execution of Express Scripts' wholesale market, value-based solutions and generic strategy, and development of Express Scripts' advanced utilization management solutions.  In addition to his work at Express Scripts, Harold serves on numerous boards including LifeWise Stl Board of Directors, St. Louis University High School Board of Trustees and IVI Board of Directors. Harold earned his doctorate in pharmacy from St. Louis College of Pharmacy.   Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business via content and relationships, email hkrish@brightspotsventures.com  About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare, proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com.  

This podcast, hosted by the Pharmacy Administration and Leadership Residents' Collaborative (PALRC), is intended to inform listeners about opportunities and concerns in the pharmacy leadership pipeline across hospitals and health systems.  Most health-system pharmacy leaders are satisfied with their decision to pursue leadership; however, many also identify opportunities for improvement, including leadership development and growth opportunities, mentorship, and work-life balance.  The development of the pipeline for residents, mid-level managers, and upper-level pharmacy executives is also explored. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Kyle Austin was born and raised in Havre, MT, a small town in Northern Montana where he learned farming and ranching on his grandfather's farm. After graduating high school, Kyle was accepted into the University of Montana's pharmacy program where he graduated with his Doctor of Pharmacy degree. Kyle has been practicing pharmacy in the state of Montana for 18 years, has taken over his grandfather's farm, and currently owns 2 pharmacies in the state of Montana called Pharm406. Kyle Austin is the only candidate in this race with agriculture experience, healthcare experience, and owns successful small businesses. Kyle believes in gun ownership, small government, and representing the people of this great state. It is time voters pick a candidate who is not handpicked or backed by corrupt out of state money. image.png Montana's Pharmacy Kyle Austin, PharmD President Pharm406, INC 1410 38th St West STE A Billings, MT 59102 Pharmacy 406-717-6100 Fax 406-534-6500 Mobile: 406-262-3098 Email: Kyle@pharm406.com www.pharm406.com image.pngimage.png

Host Nick Dorich talks with Scott D. Pope, PharmD, CEO and founder of CareerScript, about his framework distinguishing "patient" from "consumer" mindsets in healthcare, how patients arrive underinformed, and hyper-informed consumers spending their own money demand more. They discuss how real-world friction can turn pharmacists into perceived gatekeepers, and the need for pharmacies to self-assess and shift toward consumer-valued advisory care. Pope also takes time to explain how individual pharmacists need better career-navigation tools than generic personality tests and the gap CareerScript fills. https://www.careerscript.com

On Monday's show: We learn more about an investigative series from the Houston Chronicle examining how a Houston-based compounding pharmacy is stretching the boundaries of health care regulation and creating potential dangers for patients.Also this hour: We offer listeners a chance to vent their pet peeves about life in our city.And we get an update on the FIFA World Cup matches and, now that Houston has hosted its last match, we reflect on how the city did as a host city.Watch

Deprescribing is an important component of patient care as medication regimens are reassessed to ensure ongoing appropriateness, safety, and alignment with patient goals. This course reviews key deprescribing principles, including when it may be appropriate to discontinue therapy and important considerations for patient monitoring and follow-up. You will be better prepared to support evidence-based deprescribing decisions and collaborate with patients and providers to optimize medication use. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTKristin S. Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy Practice,Drake University College of Pharmacy and Health Sciences Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss key principles and clinical considerations for deprescribing.2. Compare patient-specific factors that influence evidence-based deprescribing decisions, including risks, benefits, and treatment goals.Rachel Maynard and Kristin Meyer have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-249-H01-PInitial release date: 7/6/2026Expiration date: 7/6/2029Additional CPE details can be found here.

Deprescribing is an important component of patient care as medication regimens are reassessed to ensure ongoing appropriateness, safety, and alignment with patient goals. This course reviews key deprescribing principles, including when it may be appropriate to discontinue therapy and important considerations for patient monitoring and follow-up. You will be better prepared to support evidence-based deprescribing decisions and collaborate with patients and providers to optimize medication use.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTKristin S. Meyer, PharmD, BCGP, FASCPProfessor of Pharmacy Practice,Drake University College of Pharmacy and Health SciencesGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.  CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss key principles and clinical considerations for deprescribing.2. Compare patient-specific factors that influence evidence-based deprescribing decisions, including risks, benefits, and treatment goals.Rachel Maynard and Kristin Meyer have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-249-H01-PInitial release date: 7/6/2026Expiration date: 7/6/2029Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

About this episode:   Established in 1868 as a medical school, Wayne State University has championed decades of community-engaged research and interventions in the Detroit community and throughout the state of Michigan. That work will soon take center stage with a new school of public health. In this episode: Bernard Costello, who oversees the institution's health sciences enterprise, explains why now is the right time for a devoted public health curriculum and how a university goes about starting a new school. Guest:  Bernard Costello, MD, DMD, is senior vice president for health affairs at Wayne State University, where he oversees the School of Medicine, College of Nursing, Eugene Applebaum College of Pharmacy and Health Sciences, and development of the emerging school of public health. Host:  Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. He served as the Baltimore City Commissioner of Health from 2005 to 2009.  Show links and related content:  New public health school emerging at Wayne State University—WDET How Karmanos is Partnering with Communities Against Cancer and How You Can Get Involved—Barbara Ann Karmanos Cancer Institute Healthcare Occupations—U.S. Bureau of Labor Statistics Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

Considering entrepreneurship via buying a franchise? Clark shares his most important rule before investing your hard-earned money: go work for that franchise first. Instead of relying on the sales pitch, spend several months on the job learning how the business really operates, what challenges owners face and whether the opportunity lives up to the promises. Taking this important step could save you from making a costly mistake and help you become a smarter entrepreneur. Also, Clark discusses the expansion of TrumpRx, a government prescription price comparison resource that now includes hundreds of additional generic medications. With prescription costs keeping many Americans from filling the medications they need, Clark reviews several ways to save money on prescriptions, including Costco, Sam's Club, Amazon Pharmacy, Walmart, Mark Cuban's Cost Plus Drugs and charitable programs that may provide free medications. He also explains what to do if you need an expensive brand-name medication and can't afford it, including exploring manufacturer patient assistance programs that could help lower your costs. Plus, Christa shares your #AskClark questions and Clark gives his take. All this and more on the July 1, 2026, episode of The Clark Howard Show.  Submit your questions: Ask Clark. Please note: No new episode on Friday. We wish you a safe and Happy Independence Day! Franchise Entrepreneurs: Segment 1 Ask Clark: Segment 2 New Savings On Meds: Segment 3 Ask Clark: Segment 4 Mentioned on the show: Clark Howard's Advice Before You Buy a Franchise What Is a 403(b) and How Does It Work? - Clark Howard 6 Things To Know Before Contacting the National Foundation for Credit Counseling 10 Ways To Save on Prescription Drugs - Clark Howard  How Can Discount Drug Apps Offer Such Big Savings on Prescription Medications? These Pharmacies Offer $4 Prescriptions - Clark Howard How To Comparison Shop Drug Prices Before Your Doctor Sends in a Prescription Will Mark Cuban's Prescription Company Really Save You Money?  What Is Disability Insurance and How Does It Work? - Clark Howard How To Buy Term Life Insurance in 7 Easy Steps - Clark Howard Clark.com resources: Episode transcripts Community.Clark.com  /  Ask Clark Clark.com daily money newsletter Consumer Action Center Free Helpline: 636-492-5275 Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. E. Michael Jones is a prolific Catholic writer, lecturer, journalist, and Editor of Culture Wars Magazine who seeks to defend traditional Catholic teachings and values from those seeking to undermine them. ——— EMJ Live is every Friday at 5:00pm ET Call In - Telegram: t.me/EMichaelJonesChat?videochat Youtube: https://www.youtube.com/@E_Michael_Jones Rumble: rumble.com/c/c-920885 Twitter: twitter.com/emichaeljones1 CW Magazine: culturewars.com

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

Send us Fan MailPeople trust their doctor. They do not trust the bill they get afterward.In this clip from our episode “Why Healthcare Prices Are Like Fight Club”, host John Driscoll and Mark Cuban, Co-Founder of Cost Plus Drugs, break down why pricing transparency, not just lower prices, was the real reason Cost Plus Drugs earned the trust of patients across the country.Listen to the full episode here

In this episode, Eric Huckins, Chief Growth Officer, Lumicera Health Services, Michael DePaz, Vice President of Supply Chain Specialty Pharmacy, Clarventa, and Jamie Palzkill, Director of Manufacturer Relations & Contracting, Clarventa, discuss rising drug costs, supply chain transparency, and the launch of Clarventa's net-price procurement model. They explore how innovative partnerships can help health systems reduce costs, improve medication access, and create a more sustainable pharmacy ecosystem for patients and providers.This episode is sponsored by Lumicera Health Services and Clarventa.

What can one conversation change? In this inspiring episode of Adventures in Advising, guest host Dr. Melinda Anderson sits down with newly minted Dr. Erika Nixon-Lambert to explore how a chance encounter, the guidance of caring academic advisors, and the power of community transformed her path from the cosmetics industry to earning her Doctor of Pharmacy.Together, they discuss resilience, mentorship, nontraditional student success, and why advisors have the opportunity to shape lives one conversation at a time. It's a heartfelt reminder that while dreams may be delayed, they are never denied—and that the right support can help students discover just how far they're capable of going.Follow the podcast on your favorite podcast platform!The Instagram, and Facebook handle for the podcast is @AdvisingPodcastAlso, subscribe to our Adventures in Advising YouTube Channel!Connect with Matt and Ryan on LinkedIn.

THIS WEEK IN PHARMACY PBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine Presented by SuiteRx Pharmacy Software Technologies Learn more at SuiteRx.com Episode Overview On this episode of This Week in Pharmacy, Todd Eury brings together two timely conversations focused on pharmacy transformation, advocacy, clinical education, and the future role of pharmacists in healthcare. First, Todd welcomes Brad Hart, owner of Forest Park Pharmacy, a cash-based independent pharmacy model challenging the traditional reimbursement structure many pharmacies operate under. Brad has become a powerful advocate for pharmacy transparency, using TikTok and social media to expose current PBM practices, share data, and speak directly to patients, pharmacy owners, and policymakers about the realities facing independent pharmacies. Brad's message is clear: patients deserve transparency, pharmacy owners deserve fair treatment, and the profession needs more voices willing to educate the public with facts and truth. In the second half of the episode, Todd is joined by Dr. Colby Burns and Dr. Andy Krut from the Psychedelic Pharmacists Association. This discussion helps set the groundwork for understanding psychedelics in medicine, the evolving role of pharmacists in psychedelic education, and the clinical potential of psychotropic therapies historically limited by regulation, stigma, and lack of provider education. As interest in psychedelic-assisted care grows, pharmacists must be part of the conversation. Dr. Burns and Dr. Krut explain why pharmacist education, medication safety, and clinical understanding are essential as healthcare explores emerging approaches to mental health, trauma, pain, and complex patient care. Featured Guests Brad Hart Owner, Forest Park Pharmacy Dr. Colby Burns Psychedelic Pharmacists Association Dr. Andy Krut Psychedelic Pharmacists Association Sponsored By This episode of This Week in Pharmacy is brought to you by SuiteRx Pharmacy Software Technologies. SuiteRx provides pharmacy software solutions designed to support independent pharmacies, improve workflow, enhance patient care, and help pharmacy teams operate more efficiently in today's demanding healthcare environment. Learn more at SuiteRx.com.

Too many of us are spending our days staring at screens. Little screens on our phones, big screens on the television, medium-size screens on our computers at work. Our modern lifestyles mean that we spend the vast majority of our time indoors–93%, on average. What is the time inside doing to our health? Is there an outdoor prescription to reverse dementia and depression? At The People's Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EST on Saturday, June 27, 2026, through your computer or smart phone (wunc.org).  Here is a link so you can find which stations carry our broadcast. If you can't listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3 using the link at the bottom of the page, or listen to the stream on this post starting on June 29, 2026. What Is Our Indoor Time Doing to Us? Humans used to spend a lot of time outside and had their circadian rhythms synchronized with sunlight. Living indoors as most of us do can disrupt that natural rhythm. Bright indoor lighting as well as our favorite screens in the evening can make sleep more elusive. Another consequence of focusing on screens rather than on a distant horizon of land, sea or sky is an increased risk of nearsightedness. Beyond that, screen exposure can increase the chance of brain fog, insulin resistance and immune system abnormalities. If you are spending all your time inside, your body may process that as captivity and begin to rebel. The Outdoor Prescription Dr. John La Puma pioneered culinary medicine, making the connection between what we eat and the state of our health. His analysis of the research indicates that spending just 17 mindful minutes outside each day can help reverse the damage we suffer from living indoors. He offers seven types of outdoor prescription, starting with morning light. Greeting the Sun as the Day Begins Dr. La Puma encourages us all to start our day by stepping outside for at least a few minutes under the open sky. Before coffee, before screens, morning light gets us off to the right start and helps us sleep better at the end of the day. That light exposure, even on an overcast day, helps us with deeper sleep at night. Deep sleep is critical for maintaining the brain with the glymphatic system as well as for bolstering the immune response. Before checking your email or your social media, perhaps while the coffee is brewing, make it a point to step outside for a few minutes. If that is too difficult, standing in the doorway or just looking outside through a window screen (not glass) may be enough. Bright morning light exposure is helpful in treating major depressive disorder (JAMA Psychiatry, Jan. 2016). Although the study utilized standardized indoor lights, natural light outside is brighter, even on a cloudy day. New research shows that bright light during the day reduces the risk of dementia among older people (General Psychiatry, June 24, 2026). The benefit was especially clear for those who spent more time in brighter light (at least 5,000 lux) such as one would get on an overcast day. It was even able to mitigate some of the risk associated with APOE4 genes. What Is Forest Bathing? Another practice in Dr. La Puma's outdoor prescription pad is forest bathing. This idea comes from Japan. Spending time outdoors in a forest environment is extremely healing. It can help modulate the immune system, lower blood pressure and counteract stress. Forest bathing does not require a huge investment of time, either. One Japanese study found that spending just two hours a month in a forested environment can lead to lower blood pressure and reduce techno-stress. A review has found forest bathing beneficial against stress and burnout (International Journal of Environmental Research and Public Health, July 28, 2017). https://pubmed.ncbi.nlm.nih.gov/28788101/ No Forest? No Problem Many people do not have an actual forest handy. Dr. La Puma describes his outdoor prescription for Sarah, who felt stuck inside her city apartment all the time while she cared for her elderly mother. What he prescribed for her was mindful time in the courtyard of her building, starting with very short periods of five to ten minutes. Gradually her heart rate slowed and blood pressure lowered and she began to recover from some of the chronic problems she had been suffering. Forest-bathing doesn't really require a forest. One tree, or in a pinch, a shrub, can be pressed into service. Meet Your Friends Outdoors There are few things better than spending time outdoors. One outdoor prescription that improves on spending time in nature by yourself is spending some of that outside time with friends. Walking, playing tennis, going for a picnic all help your system recalibrate. Human friends are important, but animals such as dogs or horses can also contribute to our well-being (as we contribute to theirs) when we spend time with them in a natural space. Taking Your Physical Activity Outside We all have heard how important it is for us to stay active if we want to maintain good cardiometabolic health, diminish our risk of depression and enhance our chances of staying cognitively sharp. There are advantages to outdoor activity that include but go beyond the benefits of exercise. You can accomplish the same amount of exercise with less perceived effort. In addition to light, and possibly horizons, you also get beneficial microbial exposure and a lot of joy. Gardening as an Outdoor Prescription A healthful diet begins with healthy organic soil. Gardening is a great way to experience this for yourself. We asked about people who do not have space for a backyard garden and heard about Greg, who learned to garden starting with a single basil plant indoors. Minimum Effective Dose for the Outdoor Prescription Dr. La Puma tells us that the minimum dose to get the benefits of being outdoors is just 17 minutes a day. That's not very much compared to all the time we spend inside. This Week’s Guest Dr. John La Puma is a board-certified internist, trained chef, and regenerative farmer who pioneered the Culinary Medicine movement. He is now leading the charge behind Outdoor Rx, the evidence-based response to the indoor epidemic. Dr. La Puma's latest book is Indoor Epidemic: 93% Inside Steals Sleep, Focus & Years—The 7% Outdoor Rx Restores Them The People's Pharmacy is reader supported. When you buy through links in this post, we may earn a small affiliate commission (at no cost to you). Get his free 7-Day Outdoor Reset at IndoorEpidemic.com His book is featured in the June “Touch Grass” challenge from the New York Times. John La Puma, MD, advocates for the Outdoor Rx Listen to the Podcast The podcast of this program will be available Monday, June 15, 2026, after broadcast on June 13. You can stream the show from this site and download the podcast for free. Download the mp3, or listen to the podcast on Apple Podcasts or Spotify.

Dr. Nayan Patel is the founder of Auro Wellness, a science-driven health and skincare brand focused on advancing wellness through innovative topical delivery technologies. A pharmacist for more than 30 years and an adjunct faculty member at the University of Southern California School of Pharmacy, Dr. Patel is internationally recognized for his expertise in glutathione, ingredient science, and healthy aging. After 14 years of research and development, Auro Wellness launched its patented sub-nano absorption technology, designed to improve the delivery and effectiveness of active ingredients. The brand's breakthrough product, Glutaryl™, is the first topical glutathione formula developed to provide systemic wellness benefits through skin absorption. Auro has since expanded into skincare, leveraging its patented technology to deliver antioxidants and peptides deeper into the skin for clinically proven results. Its Copper Tri-Peptide Serum reflects the growing shift toward science-backed skincare focused on repair, resilience, and skin longevity. Through Auro Wellness, Dr. Patel continues to bridge pharmaceutical science and beauty innovation to help consumers achieve healthier aging from the inside out. In this episode, Dr. Patel also discusses: Why copper peptides are emerging as a hero ingredient in modern skincare Why longevity should be the goal—not just treating symptoms with drugs The science behind why the aging process begins as early as age 25 What 14 years of research revealed about glutathione and cellular health The hidden toxins in your daily routine that may be accelerating aging How oxidative stress impacts energy, inflammation, and long-term health The future of preventative wellness and healthy aging from the inside out We hope you enjoy this episode and gain valuable insights into Dr. Patel's journey and the growth of Auro Wellness. Don't forget to subscribe to the Glam & Grow podcast for more in-depth conversations with the most incredible brands, founders, and more. Be sure to check out Auro Wellness at www.aurowellness.com and on Instagram at @aurowellness Rated #1 Best Beauty Business Podcast on FeedPost This episode is brought to you by Wavebreak Leading direct-to-consumer brands hire Wavebreak to turn email marketing into a top revenue driver. Most eCommerce brands don't email right... and it costs them. At Wavebreak, our eCommerce email marketing agency helps qualified brands recapture 7+ figures of lost revenue each year. From abandoned cart emails to Black Friday campaigns, our best-in-class team manage the entire process: strategy, design, copywriting, coding, and testing. All aimed at driving growth, profit, brand recognition, and most importantly, ROI. Curious if Wavebreak is right for you? Reach out at Wavebreak.co